Limited official informationFDA Drug Enforcement ReportsRecall date: May 13, 2026

Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. C...

Full official product description

Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.), Mumbai 400 030, India, Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 64980-688-10.

1Is my item affected?

Compare the complete identifiers. Name similarity alone is not a confirmed match.

Identifiers to compare

NDC 64980-688-10

Affected variants from the official event record
Product or model	Codes and lots	Quantity	Recall number
Enalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceu...	Lot #: GEH25023, Expires: 6/30/2027	675 bottles	D-0520-2026

2What is the risk?

The agency's statement is shown without a site-authored severity score.

Failed Impurities/Degradation Specifications:Out of specification result occurred in Organic Impurities Test

Agency classification: Class II

3What should I do?

Only instructions associated with this recall event qualify as an action.

Consumer action is not available in the associated official record. The site does not infer or generate a replacement.

Verify on the official source

The linked agency record controls if any information differs.

Official evidence

U.S. Food and Drug Administration authoritative
openFDA Drug authoritative

Official scope

Distribution reported by the agency

Nationwide in the USA

Distribution is context, not a confirmed item match. Compare the model, lot, UPC, NDC, or serial number above.

Material change history

No material affected-item, risk, action, or status change has been recorded since this page entered the tracker.